Starlix (Novartis Pharmaceuticals Corporation)
Welcome to the PulseAid listing for the Starlix drug offered from Novartis Pharmaceuticals Corporation. This Glinide [EPC],Potassium Channel Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Novartis Pharmaceuticals Corporation |
| NON-PROPRIETARY NAME: | nateglinide |
| SUBSTANCE NAME: | NATEGLINIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Glinide [EPC],Potassium Channel Antagonists [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2000-12-04 |
| END MARKETING DATE: | 0000-00-00 |
Starlix HUMAN PRESCRIPTION DRUG Details:
| Item Description | Starlix from Novartis Pharmaceuticals Corporation |
| LABELER NAME: | Novartis Pharmaceuticals Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 60(mg/1) |
| START MARKETING DATE: | 2000-12-04 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0078-0351_778b42d2-8dfe-4d76-a16b-c354ecbedf31 |
| PRODUCT NDC: | 0078-0351 |
| APPLICATION NUMBER: | NDA021204 |
Other NATEGLINIDE Pharmaceutical Manufacturers / Labelers:
